Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies.
about
Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activityBlasts from the pastThe role of peroxisome proliferator-activated receptors in carcinogenesis and chemopreventionRegulation of the nongenomic actions of retinoid X receptor-α by targeting the coregulator-binding sitesNutritional protective mechanisms against gut inflammationProbiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activationAdipokines and the role of visceral adipose tissue in inflammatory bowel diseaseCiglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shockIntegrated expression profiles of mRNA and miRNA in polarized primary murine microglia.Hepatocyte RXRalpha deficiency in matured and aged mice: impact on the expression of cancer-related hepatic genes in a gender-specific mannerEffects of mesalamine (5-aminosalicylic acid) on bacterial gene expression.The importance of the retinoid X receptor alpha in modulating inflammatory signaling in acute murine colitis.A Systems Pharmacology Approach to Determine Active Compounds and Action Mechanisms of Xipayi KuiJie'an enema for Treatment of Ulcerative colitis.Nuclear receptors, mitochondria and lipid metabolismPPARγ negatively regulates T cell activation to prevent follicular helper T cells and germinal center formation.Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma.The Role of Peroxisome Proliferator-Activated Receptor beta/delta on the Inflammatory Basis of Metabolic Disease.Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasisThe PXR is a drug target for chronic inflammatory liver disease.Gastrointestinal Cytoprotection by PPARγ Ligands.Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease.Peroxisome proliferator activated receptor-γ and traumatic brain injury.Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoidsH(2)O(2) production in species of the Lactobacillus acidophilus group: a central role for a novel NADH-dependent flavin reductase.Butyrate produced by commensal bacteria potentiates phorbol esters induced AP-1 response in human intestinal epithelial cellsNuclear receptors. I. PPAR gamma in the gastrointestinal tract: gain or pain?Small therapeutic molecules for the treatment of inflammatory bowel diseasePeroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel diseaseA role for the peroxisome proliferator-activated receptor alpha in T-cell physiology and ageing immunobiology.Antimicrobial peptides and gut microbiota in homeostasis and pathology.The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat.Retinoids as a potential treatment for experimental puromycin-induced nephrosis.PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammationUse of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria.PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophagesImmune networks in animal models of inflammatory bowel disease.Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cellsSignal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitisMesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease.Insulinotropic and anti-inflammatory effects of rosiglitazone in experimental autoimmune diabetes.
P2860
Q24322799-9277411F-3D23-408A-86C1-91C71E8BC1FFQ24563415-6AAD2B67-BAE8-4043-B2A5-A7574C8FA8FDQ24601222-9E9A17F4-809A-48C6-90AB-482AA3E4C7B8Q27025972-C6B93B94-BBFF-4511-A445-3233600F2B8CQ27028202-7D67A7C4-6268-4FE1-AFD9-5C71BAAC2D68Q27327276-67F4EA99-0204-4955-B574-603C728020FCQ28070229-C12B91C8-4D73-47E2-9F2F-4A98A48D55C2Q28575608-8958FED3-E512-4642-AFC3-A311E2634544Q31144077-69E43122-64BB-41C9-AD6F-DC12C0F74634Q33364577-2E90CA57-764A-4745-AE3C-7601E8C0EDB5Q33406895-89B5370E-3611-40DC-A3AE-28DC71716FB4Q33565057-0BB0D690-D38F-405D-8EC9-C6A1654036E8Q33681862-DDE076B2-CEA1-4A47-A574-D56B6FD6465FQ33699001-5DE12B78-FE67-4629-ADE3-AA48AA77FCC4Q33748674-EA1D6C19-6B1A-429C-AE39-873405E35635Q33911192-0468A73B-718B-483E-ADBA-959A353B58C5Q34035340-DD9F2F83-47B1-4F6A-9A42-BFBC773811A7Q34094462-07E09892-DBAB-4EAA-8994-41AA269197F2Q34118368-08E18971-FC13-4D2F-AB0A-86F5C1447DB4Q34159427-E70F09DA-C351-49DD-BE5C-117EEA7BFC9FQ34233126-C6DF08AB-04B2-4802-9A49-BE17535CBA98Q34271250-E3064FE9-E256-40B3-B199-AE121C4666FDQ34291196-99BDD445-ADE1-438E-92B9-FB0A1260E56BQ34401547-0356B104-2646-463E-AC30-568535287DBBQ34541325-9E311A80-A63B-4C9E-AC33-475EFD7989DAQ34565656-E7397B02-FFC4-4857-8A60-C586FC40B619Q34600992-9B9F3A45-CF6F-45D1-BDD1-7B62F4AC19B5Q34804346-80FD54B4-8AEB-4B3B-A205-99CFA7781222Q34892990-809D5DCF-08AA-4753-A389-12A5C7CAC5B5Q34987870-4972B443-576E-4988-9D5D-A5667D5DCA91Q35044970-D8DE7120-B303-4C4C-934A-C2F84866A1BBQ35045441-75A6C49A-673E-4E22-AFE0-72E541D9894FQ35053566-4000A839-80EA-414C-9693-47A585F8E137Q35140083-F0AD3FEA-ECA3-41A5-8B1F-2BEC56842531Q35144057-C24F0502-44A7-4407-9FF8-AF05AEF78462Q35193871-8BF6FEB4-DE5E-4381-8B59-F812851C539FQ35439554-23ECF933-924E-492A-A7BC-480449A12F3FQ35569874-194F3746-2D63-4EDA-9109-2C0978DB6155Q35593129-30781DA8-8F7F-4F33-8111-C119ACE04FFEQ35612704-D9E70A37-C511-4411-8F18-D2B660F6EA02
P2860
Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Attenuation of colon inflammat ...... or new therapeutic strategies.
@ast
Attenuation of colon inflammat ...... or new therapeutic strategies.
@en
type
label
Attenuation of colon inflammat ...... or new therapeutic strategies.
@ast
Attenuation of colon inflammat ...... or new therapeutic strategies.
@en
prefLabel
Attenuation of colon inflammat ...... or new therapeutic strategies.
@ast
Attenuation of colon inflammat ...... or new therapeutic strategies.
@en
P2093
P2860
P50
P356
P1476
Attenuation of colon inflammat ...... or new therapeutic strategies.
@en
P2093
B Derijard
J F Colombel
K Schoonjans
M D Leibowitz
M Peuchmaur
P Desreumaux
P2860
P304
P356
10.1084/JEM.193.7.827
P407
P577
2001-04-01T00:00:00Z